# Telomir Pharmaceuticals, Inc.: Form 8-K, filed Jul 22, 2025

- Company: [Telomir Pharmaceuticals, Inc.](/companies/telo.md) (CIK 1971532)
- Form: 8-K
- Filed: 2025-07-22
- Accepted by EDGAR: Jul 22, 2025, 16:01 ET
- Period: 2025-07-18
- Accession: 0001641172-25-020563
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971532/000164117225020563/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971532/000164117225020563/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971532/000164117225020563/form8-k.htm

Filed Jul 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-020563. Last ingested by Listed: Nov 5, 2026, 18:44 ET. No prices; not investment advice.